Get the Stockscreener App
6.44
5.71%
-0.39
After Hours:
6.41
-0.03
-0.47%
Nu Skin Enterprises Inc Stock (NUS) Forecast
The Nu Skin Enterprises Inc (NUS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.23, representing a +105.45% increase from the current price of $6.44. The highest analyst price target is $14.20, and the lowest is $12.26.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NUS Price Target
Average 16.86
(+161.87% Upside)
Is Nu Skin Enterprises Inc (NUS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.26 | Neutral |
| STOCH(9,6) | 22.07 | Neutral |
| STOCHRSI(14) | 10.09 | Buy |
| MACD(12,26) | -0.2027 | Sell |
| ADX(14) | 25.65 | Sell |
| William %R | -97.47 | Buy |
| CCI(14) | -122.20 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.073
Sell
|
7.1083
Sell
|
| MA20 |
7.5525
Sell
|
7.3333
Sell
|
| MA50 |
7.3408
Sell
|
7.3747
Sell
|
| MA100 |
7.2639
Sell
|
7.494
Sell
|
| MA200 |
7.9647
Sell
|
8.7335
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NUS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NUS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.26 indicates that NUS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.07 indicates that NUS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.09 indicates that NUS is oversold. This suggests that NUS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.65 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -122.2 indicates that NUS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NUS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nu Skin Enterprises Inc financial reports and earnings history, Nu Skin Enterprises Inc (NUS) stock could reach $33.49 by 2030, $8.7254 by 2040 and $72.18 by 2050. See the projected annual prices until 2050 of the Nu Skin Enterprises Inc stock below:
- Nu Skin Enterprises Inc (NUS) is expected to reach an average price of $7.4572 in 2035, with a high prediction of $6.9942 and a low estimate of $6.9212. This indicates an $15.80% rise from the last recorded price of $6.44.
- Nu Skin Enterprises Inc (NUS) stock is projected to chart a bullish course in 2040, with an average price target of $9.0297, representing an $40.21% surge from its current level. The forecast ranges from a conservative $8.7349 to a sky-high $8.7254.
- Our analysts predict Nu Skin Enterprises Inc (NUS) to jump 581.28% by 2045, soaring from $44.43 to an average price of $43.87, potentially reaching $43.19. While $44.43 is the low estimate, the potential upside is significant.
- Nu Skin Enterprises Inc (NUS) stock is expected to climb by 2050, reaching an average of $70.16, a $989.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $72.18 and $73.02, respectively, highlighting the market's uncertainty.
Nu Skin Enterprises Inc Stock (NUS) Year by Year Forecast
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2025
Nu Skin Enterprises Inc Stock (NUS) is expected to reach an average price of $12.33 in 2025, with a high prediction of $24.08 and a low estimate of $0.5705. This indicates an +91.41% rise from the last recorded price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $11.85 | $12.26 | $14.20 | +84.06% |
| June, 2025 | $1.5766 | $4.1866 | $6.9001 | -75.52% |
| July, 2025 | $3.5822 | $0.5705 | $5.7505 | -44.38% |
| August, 2025 | $9.0292 | $1.554 | $14.16 | +40.21% |
| September, 2025 | $12.68 | $8.7945 | $14.46 | +96.84% |
| October, 2025 | $13.96 | $10.52 | $15.47 | +116.69% |
| November, 2025 | $17.05 | $13.06 | $20.48 | +164.78% |
| December, 2025 | $16.87 | $16.62 | $24.08 | +161.97% |
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2026
The predicted value for Nu Skin Enterprises Inc (NUS) in 2026 is set at an average of $23.78. Estimates vary from a peak of $34.02 to a trough of $13.53, indicating an +269.20% surge from the present price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $20.47 | $14.39 | $23.43 | +217.82% |
| February, 2026 | $20.82 | $18.19 | $22.08 | +223.37% |
| March, 2026 | $24.55 | $18.89 | $27.98 | +281.24% |
| April, 2026 | $19.01 | $16.93 | $33.16 | +195.20% |
| May, 2026 | $24.21 | $16.01 | $24.73 | +275.89% |
| June, 2026 | $22.09 | $20.59 | $24.81 | +243.08% |
| July, 2026 | $29.64 | $22.28 | $30.61 | +360.30% |
| August, 2026 | $32.51 | $29.37 | $34.02 | +404.82% |
| September, 2026 | $28.27 | $26.21 | $32.76 | +338.96% |
| October, 2026 | $27.95 | $24.15 | $28.48 | +333.95% |
| November, 2026 | $23.39 | $22.77 | $28.21 | +263.25% |
| December, 2026 | $13.81 | $13.53 | $24.20 | +114.47% |
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nu Skin Enterprises Inc (NUS) is $22.84, with a high forecast of $32.66 and a low forecast of $13.03. This indicates an +254.72% increase from the last price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.85 | $13.03 | $15.44 | +130.57% |
| February, 2027 | $21.02 | $13.62 | $21.59 | +226.34% |
| March, 2027 | $24.32 | $17.63 | $24.54 | +277.71% |
| April, 2027 | $29.49 | $23.29 | $29.79 | +357.95% |
| May, 2027 | $25.95 | $22.88 | $29.34 | +302.93% |
| June, 2027 | $22.37 | $20.80 | $32.66 | +247.32% |
| July, 2027 | $24.56 | $19.40 | $25.88 | +281.44% |
| August, 2027 | $22.46 | $22.03 | $28.81 | +248.78% |
| September, 2027 | $23.80 | $18.04 | $24.83 | +269.57% |
| October, 2027 | $22.26 | $21.16 | $25.87 | +245.61% |
| November, 2027 | $19.94 | $19.45 | $24.90 | +209.70% |
| December, 2027 | $25.11 | $19.26 | $25.32 | +289.96% |
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2028
In 2028, Nu Skin Enterprises Inc (NUS) is projected to reach an average price of $19.41, with a high projection of $28.16 and a low estimate of $10.66. This indicates an +201.40% rise from the last price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $19.86 | $19.72 | $26.56 | +208.39% |
| February, 2028 | $13.41 | $13.33 | $21.36 | +108.19% |
| March, 2028 | $18.79 | $13.52 | $20.90 | +191.71% |
| April, 2028 | $19.88 | $10.66 | $20.61 | +208.74% |
| May, 2028 | $23.17 | $19.75 | $24.63 | +259.81% |
| June, 2028 | $24.17 | $22.42 | $26.44 | +275.29% |
| July, 2028 | $25.04 | $23.24 | $27.10 | +288.75% |
| August, 2028 | $22.29 | $21.79 | $28.16 | +246.19% |
| September, 2028 | $23.84 | $21.22 | $24.27 | +270.21% |
| October, 2028 | $22.82 | $21.35 | $25.34 | +254.33% |
| November, 2028 | $19.15 | $17.45 | $23.18 | +197.32% |
| December, 2028 | $18.15 | $16.75 | $20.28 | +181.90% |
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2029
The 2029 price forecast for Nu Skin Enterprises Inc Stock (NUS) is $13.06 on average, with a high prediction of $24.67 and a low estimate of $1.4527. This represents an +102.82% increase from the previous price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.90 | $13.54 | $19.38 | +131.41% |
| February, 2029 | $9.7201 | $8.9601 | $15.50 | +50.93% |
| March, 2029 | $10.42 | $8.9554 | $10.79 | +61.76% |
| April, 2029 | $5.2041 | $4.9541 | $10.68 | -19.19% |
| May, 2029 | $3.9329 | $3.5011 | $7.1359 | -38.93% |
| June, 2029 | $5.4199 | $3.7946 | $5.9446 | -15.84% |
| July, 2029 | $7.7269 | $5.0917 | $8.2834 | +19.98% |
| August, 2029 | $7.4257 | $5.5222 | $9.1687 | +15.31% |
| September, 2029 | $1.8927 | $1.4527 | $8.0209 | -70.61% |
| October, 2029 | $2.1715 | $1.4845 | $3.2563 | -66.28% |
| November, 2029 | $3.3285 | $2.1567 | $4.0232 | -48.32% |
| December, 2029 | $30.26 | $2.272 | $24.67 | +369.88% |
Nu Skin Enterprises Inc Stock (NUS) Price Forecast for 2030
Nu Skin Enterprises Inc Stock (NUS) is expected to reach an average price of $41.87 in 2030, with a high forecast of $51.07 and a low forecast of $32.68. This signifies an +550.20% surge from the last price of $6.44.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $31.92 | $32.68 | $33.49 | +395.69% |
| February, 2030 | $37.16 | $35.43 | $35.16 | +476.99% |
| March, 2030 | $42.04 | $41.96 | $40.38 | +552.86% |
| April, 2030 | $39.88 | $41.01 | $39.09 | +519.26% |
| May, 2030 | $36.70 | $37.51 | $37.18 | +469.92% |
| June, 2030 | $33.70 | $35.46 | $35.97 | +423.27% |
| July, 2030 | $39.21 | $33.33 | $37.94 | +508.87% |
| August, 2030 | $35.58 | $37.40 | $38.18 | +452.52% |
| September, 2030 | $34.75 | $35.68 | $35.13 | +439.65% |
| October, 2030 | $43.91 | $35.07 | $38.75 | +581.77% |
| November, 2030 | $54.04 | $44.97 | $49.44 | +739.08% |
| December, 2030 | $50.71 | $52.23 | $51.07 | +687.39% |
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):